CSTL

#2185

Castle Biosciences, Inc. Common Stock

29.5700

-3.05%

Сектор:

Базовая:

Валюта прибыли:

Дневной диапазон

Годовой диапазон

Дневное изменение

-3.05%

Месячное изменение

-30.88%

6-месячное изменение

+20.13%

Годовое изменение

+20.13%

Предыдущее закрытие

30.5000

Open

29.5700

Bid

Ask

Low

29.5700

High

29.5700

Объем

Open full chart

Financials

Overview Отчетность Statistics Dividends

Quarterly Annual

Cash from operating activities 9.87 M18.98 M41.66 M5.63 M64.87 M64.35 M 64.35 M Cash from investing activities 4.75 M66.66 M166.54 M16.18 M50.14 M60.37 M 60.37 M Cash from financing activities 305.89 M5.42 M1.51 M2.3 M6.14 M6.96 M 6.96 M Free cash flow 5.11 M15.5 M36.02 M-8 M36.54 M28.33 M 28.33 M

CSTL

Financials

Новости

RCKT's Q4 Loss Narrower Than Estimated, Pipeline in Focus

PBYI Q4 Earnings & Sales Beat Estimates, Stock Down on Weak 2026 View

TGTX Q4 Earnings Lag Estimates, Briumvi Sales Drive Top Line

PRGO Q4 Earnings Miss, Sales Beat, Stock Down on Weak 2026 View

Intellia Rises on Q4 Earnings & Revenue Beat, Focuses on Pipeline

Pacira BioSciences Q4 Earnings and Revenues Miss Estimates, Stock Down

Kymera Q4 Loss Wider Than Expected, Cash Boost Extends Runway

Castle Biosciences, Inc. (CSTL) Q4 2025 Earnings Call Transcript

Castle Biosciences, Inc. (CSTL) Reports Q4 Loss, Beats Revenue Estimates

Castle Biosciences: объем тестов вырос на 42%, выход на рынок AD

Castle Biosciences Q4 2025 slides: test volumes surge 42%, enters AD market

Castle Biosciences: доходы, прибыль побили прогнозы в Q4